25/02/2019 19:19:59

CLASS ACTION UPDATE for IMMU, DXC and W: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

Immunomedics, Inc. (NASDAQ: IMMU)

Class Period: February 8, 2018 - January 18, 2019

Lead Plaintiff Deadline: February 25, 2019

Join the action: https://www.zlk.com/pslra-1/immunomedics-inc-loss-form?wire=3

About the lawsuit: Immunomedics, Inc. allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (i) Immunomedics’ Morris Plains, New Jersey drug substance manufacturing facility was not in compliance with FDA requirements; (ii) the Company’s Quality Control Unit did not possess the  authority to investigate and correct critical FDA violations occurring  at  the  Morris Plains, New Jersey facility; (iii) the Company suffered a February 2018 data integrity breach at the Morris Plains, New Jersey facility which, among other issues, included the backdating records and manipulation of bioburden samples; (iv) the Company’s Chemistry, Manufacturing and Control data submitted in connection with its BLA for sacituzumab govitecan was insufficient to support FDA approval; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

To learn more about the Immunomedics, Inc. class action contact jlevi@levikorsinsky.com.

DXC Technology Company (NYSE: DXC)

Class Period: February 8, 2018 - November 6, 2018

Lead Plaintiff Deadline: February 25, 2019

Join the action: https://www.zlk.com/pslra-1/dxc-technology-company-loss-form?wire=3

About the lawsuit: During the class period, DXC Technology Company allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had changed or planned to change the operations of its sales teams, deploying generalized sales teams as opposed to the specialized teams that were better capable of delivering specialized services to its clients; (b) the Company’s workforce optimization strategy of sharply reducing staff while reducing costs was resulting in a shortage of sales personnel who could execute on demand for services, thereby risking and ultimately losing sales and revenue opportunities; (c) in light of the above, the Company’s revenue and financial performance guidance for the fiscal year 2019 and its reaffirmation of the guidance during the Class Period was without a reasonable basis.

To learn more about the DXC Technology Company class action contact jlevi@levikorsinsky.com.

Wayfair Inc. (NYSE: W)

Class Period: Class A shares between August 2, 2018 and October 31, 2018

Lead Plaintiff Deadline: March 11, 2019

Join the action: https://www.zlk.com/pslra-1/wayfair-inc-loss-form?wire=3

About the lawsuit: Throughout the class period, Wayfair Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Wayfair had been experiencing significantly diminished demand for its online product offerings and had significantly increased advertising spending to grow sales; (2) Wayfair, which was already more than one-third of the way into 3Q18 when it announced its 2Q18 results on August 2, 2018, had already dramatically increased advertising spending for 3Q18; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the Wayfair Inc. class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Toll Free: (877) 363-5972

Fax: (212) 363-7171

www.zlk.com 

250x148_zlk.jpg

Related content
27 Jun - 
DXC Technology and Zafin Partner to Help Banks Manage C..
27 Jun - 
DXC Technology and Zafin Partner to Help Banks Manage C..
29 May - 
Immunomedics to Participate in Upcoming Healthcare Conf..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
uBreakiFix Expands Dallas Footprint With Grand Prairie Store
2
Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
3
Translate Bio Appoints George Demetri, M.D., to its Board of Directors
4
Aemetis India Expands Revenues to $50 Million Per Year Run Rate Driven by Biodiesel Shipments to Large Refiners
5
American Premium Water Corp (OTC: HIPH) Announces Singleseed.com as Launch Retailer for its Pet CBD Water Product

Related stock quotes

Immunomedics Inc 14.22 -3.1% Stock price decreasing
Wayfair Inc Class A 151.02 0.6% Stock price increasing
DXC Technology Company 56.97 0.3% Stock price increasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
16 July 2019 04:03:31
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB7 - 2019-07-16 05:03:31 - 2019-07-16 04:03:31 - 1000 - Website: OKAY